Aveo Capital Partners LLC Purchases Shares of 3,934 Church & Dwight Co., Inc. (NYSE:CHD)

Aveo Capital Partners LLC purchased a new stake in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,934 shares of the company's stock, valued at approximately $412,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Manchester Capital Management LLC increased its position in shares of Church & Dwight by 7.7% during the 4th quarter. Manchester Capital Management LLC now owns 3,124 shares of the company's stock valued at $327,000 after purchasing an additional 223 shares during the last quarter. Littlejohn Financial Services Inc. purchased a new position in Church & Dwight in the fourth quarter valued at about $1,811,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Church & Dwight during the 4th quarter valued at approximately $4,949,000. Certuity LLC purchased a new stake in shares of Church & Dwight during the 4th quarter worth approximately $402,000. Finally, Portfolio Design Labs LLC raised its holdings in shares of Church & Dwight by 31.2% in the 4th quarter. Portfolio Design Labs LLC now owns 29,313 shares of the company's stock worth $3,069,000 after purchasing an additional 6,978 shares during the period. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on CHD shares. Stifel Nicolaus raised their target price on Church & Dwight from $103.00 to $105.00 and gave the stock a "hold" rating in a research report on Monday, February 3rd. Piper Sandler lowered their price objective on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. JPMorgan Chase & Co. increased their target price on shares of Church & Dwight from $99.00 to $107.00 and gave the stock an "underweight" rating in a research report on Thursday, January 16th. Royal Bank of Canada reissued a "sector perform" rating and issued a $105.00 price target on shares of Church & Dwight in a research report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of Church & Dwight from $114.00 to $115.00 and gave the company a "buy" rating in a report on Monday, November 4th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $111.53.

Church & Dwight Price Performance

Shares of NYSE:CHD traded up $0.47 during trading on Wednesday, reaching $104.33. The company had a trading volume of 1,076,962 shares, compared to its average volume of 1,555,880. The company has a fifty day moving average of $105.40 and a two-hundred day moving average of $104.66. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $25.66 billion, a P/E ratio of 44.02, a price-to-earnings-growth ratio of 3.34 and a beta of 0.59. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $113.50.

Church & Dwight (NYSE:CHD - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, meeting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period in the previous year, the firm earned $0.65 EPS. Equities research analysts forecast that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be paid a $0.295 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.18 annualized dividend and a yield of 1.13%. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. Church & Dwight's dividend payout ratio is currently 49.79%.

Insider Buying and Selling at Church & Dwight

In other news, CAO Joseph James Longo sold 7,780 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $112.44, for a total transaction of $874,783.20. Following the completion of the sale, the chief accounting officer now owns 400 shares of the company's stock, valued at approximately $44,976. This represents a 95.11 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Maynadier Patrick D. De sold 45,120 shares of the firm's stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $112.19, for a total transaction of $5,062,012.80. Following the completion of the transaction, the executive vice president now owns 10,325 shares in the company, valued at $1,158,361.75. This represents a 81.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,422 shares of company stock worth $11,424,351 over the last ninety days. Insiders own 1.40% of the company's stock.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.